Briefly summarized, embodiments of the present invention are directed to a dressing for use in protectively covering a medical device placed on and/or through the skin surface of a patient. Examples of such devices include infusion needles for accessing subcutaneously implanted access ports, catheters of various types and purposes, insulin infusion needles, etc. When placed atop the skin-placed medical device, the dressing prevents bacteria and other undesired microbes or external contaminants from reaching the medical device and its insertion site through the skin. Further, the dressing is configured such that water vapor may be transmitted therethrough, thus enabling the insertion site to breathe and prevent undesired moisture buildup under the dressing.
In one embodiment, a dressing for covering a medical device on a skin surface of a patient is disclosed and comprises a dressing portion that is configured to rest against a skin surface of a patient, with the dressing portion defining a hole, and a polymeric cover film that is at least indirectly attached to the dressing portion. The cover film includes a pliable domed portion aligned with the hole of the dressing portion. The pliable domed portion defines a cavity that configured to receive therein the medical device when the dressing is placed on the skin of the patient.
These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.
A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.
For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”
Embodiments of the present invention are generally directed to a dressing for use in protectively covering a medical device placed on and/or through the skin surface of a patient. Examples of such devices include infusion needles for accessing subcutaneously implanted access ports, catheters of various types and purposes, insulin infusion needles, etc. When placed atop the skin-placed medical device, the dressing prevents bacteria and other undesired microbes or external contaminants from reaching the medical device and its insertion site through the skin. Further, the dressing is configured such that water vapor may be transmitted therethrough, thus enabling the insertion site to breathe and prevent undesired moisture buildup under the dressing.
In accordance with one embodiment, the dressing is shaped and configured so as to suitably cover medical devices that extend some distance above the skin surface without causing deformation, “tenting,” and/or peel-away of the dressing from the skin due to tension between the dressing surface and the medical device. In addition, the dressing includes a pliable domed cover that can cover the medical device, conform to the medical device if necessary, and deform when contacted so as to enhance patient comfort, all while providing isolation for the medical device from potential contaminants. In one embodiment, the domed cover also assists in securing the medical device in place on the patient skin.
Reference is first made to
In the present embodiment, the perimeter portion 14 includes a suitably strong yet bendable material such as a non-woven fabric including polyester or other suitable material. Though shown as circular, the shape of the perimeter portion 14 can include other shapes, such as square, oval, triangular, etc.
The dressing 10 further includes a central portion 16 that is pliable and breathable so as to enable moisture transfer therethrough and prevent undesired moisture buildup underneath the dressing 10. As such, in the present embodiment the central portion 16 includes polyurethane or other suitable thermoplastic or material that possesses a relatively high moisture vapor transfer rate (“mvtr”) so as to enable suitable moisture transmission therethrough. In one embodiment, a polyurethane sheet with a thickness of between about 0.8 mil to about 2 mils is employed for the central portion 16, though it is appreciated that other sheet thicknesses of differing moisture vapor transfer rates can be employed, including low mvtr values.
In the present embodiment, the central portion 16 is suitably transparent to enable inspection of the medical device/insertion site under the dressing 10 to be made from outside the dressing. Use of a polyurethane central portion provides such transparency, as do other suitable thermoplastics. In another embodiment, the central portion 16 is semi-transparent or opaque.
Because it is manufactured from the pliable material of the central portion 16, the domed portion 18, though given a raised configuration so as to extend away from the patient skins, is collapsible in this and other embodiments as to increase patient comfort.
As part of the central portion 16, the domed portion 18 in the present embodiment includes the same material as the central portion (such as polyurethane), though in other embodiments the domed portion can include a material that differs from other portions of the dressing 10, including the central portion. Further, in the present embodiment the underside of the regions of the central portion 16 that surround the domed portion include the adhesive 20 (as does the underside of the perimeter portion 14) so as to adhere to the skin when the dressing 10 is placed thereon, while the domed portion 18 includes no such adhesive so it can remain raised from the skin surface and not interfere with the medical device. In other embodiments, the configuration of adhesive application can vary, such as the application of adhesive to the underside of the domed portion 18 so as to adhere the domed portion to the medical device it covers. It is also appreciated that one or more antimicrobial agents can be applied to the underside or other suitable portions of the dressing so as to prevent the formation of microbes. In one embodiment, the antimicrobial agent can include silver, chlorhexidine gluconate (“CHG”), isopropyl alcohol (“IPA”), etc. Further details regarding antimicrobial agents that may be used according to one embodiment are found in U. S. Patent Application Publication No. 2013/0110025, filed Jul. 4, 2011, and entitled “Dressing Device for Use with a Cannula or a Catheter,” which is incorporated herein by reference in its entirety.
As seen in
It is appreciated that the shape, size, and configuration of the domed portion 18 of the dressing 10 and other dressing described herein can be modified as needed to cover differing types and sizes of infusion needles, catheters, infusion pumps, and other medical devices. As such, each domed portion can be uniquely shaped to fit over the corresponding infusion set/medical device. In another embodiment, the domed portion is universally sized to fit a variety of infusion needles or other medical devices. Of course, the particular shapes and sizes of the domed portion 18 can vary from what is shown and described herein. In yet another embodiment, the dressing can include more than one domed portion to cover multiple medical devices placed on the patient's skin.
The domed portion 118 is separately formed with respect to the perimeter portion 114 in the present embodiment, is pliable, and includes a lip 118A to enable it to be secured via adhesive or other fixation within a hole defined in the perimeter portion 114. The domed portion 118 can include shape features 123 that provide some rigidity and/or reinforcement thereto. Note that, despite its name, the central portion in this and other embodiments can be placed in a non-centered location with respect to the dressing body.
In one embodiment, it is appreciated that one or more reinforcement features can extend across the domed portion of the dressings described herein to provide some rigidity and/or reinforcement thereto. The reinforcement feature can include, for instance, an adhesive strip, non-woven material that is bonded to the domed portion 218, etc.
Reference is now made to
In the present embodiment, the dressing 210 includes a plurality of layers as will be further described below. As seen in
The release liner 250 includes a hole 270 defining a shape corresponding to domed portion 218. A first notch 271 is included at the side edge of the release liner 250, while a second notch 272 is included in the release liner proximate the portion of the hole 270 corresponding to the point 228 of the domed portion 218. Generally, the shape of the release liner 250 and the position and configuration of the above-named aspects of the release liner are supportive of other dressing components, as discussed below.
A dressing portion 252 is included to serve as a base for the dressing 210 when placed on the skin of the patient and to provide a skin-based barrier to protect the insertion site of the infusion needle or other medical device to be covered by the dressing. As seen in
In the present embodiment, the dressing portion 252 includes a non-woven, spunlace polyester material, though it is appreciated that various other materials can be acceptably used. For instance, a knitted polyester could be employed. Desired characteristics for the dressing material include one that can suitably carry the adhesives disposed thereon (discussed below), offers suitable tensile and general strength for retaining the infusion needle assembly and its tubing without tearing and for supporting the domed portion 218, and suitably prevents rolling of the cover film, discussed below.
The bottom surface of the dressing portion 252 includes an adhesive configured to bond the dressing portion to the skin of the patient when the dressing 210 is placed. Though various biocompatible adhesives may be used, in the present embodiment an acrylic adhesive, such as LOCTITE® 737NA acrylic adhesive, is employed for the bottom surface of the dressing portion 252. Other possible adhesives include silicone-based, urethane-based, and hydrocolloid adhesives.
A cover film 254 is included atop the dressing portion 252 to provide a cover for the infusion needle assembly or other skin-placed medical device to be covered by the dressing 210. As seen in
In greater detail and as has been described in connection with other embodiments, the pliable domed portion 218 and its point 228 are defined by a raised central portion of the otherwise flat cover film 254 to define the cavity 224 for protecting and isolating the skin-placed medical device, though it is appreciated that the domed portion could be located in other positions on the dressing 210 as well. The particular size, shape, and configuration of the domed portion 218 can vary from what is shown and described herein. The domed portion 218 illustrated in
In the present embodiment, the cover film 254 includes a thermoplastic polyurethane film, such as ARGOMEDPLUS® 18411 polyurethane material available from Argotec LLC of Greenfield, Mass., though other suitable materials, including other polymeric materials, could be utilized. Desired characteristics of the material for film cover 254 in one embodiment include: suitably high resilience to deformation/elongation; sufficient vapor transmissiveness; and abrasion, puncture and tear resistance. The thickness of the thermoplastic polyurethane film to be used in manufacturing the cover film 254 is about 2.25 mils, in one embodiment, though the thickness can vary according to the material selected. In another embodiment, the thickness of the thermoplastic polyurethane film is from about 1.5 to about 2.5 mils.
The use of polyurethane as the cover film material enables the domed portion 218 to be pliable while retaining sufficient strength to form its dome shape. Further, the above-described thicknesses of the polyurethane cover film material enables the dome portion 218 to retain a desired moisture vapor transfer rate therethrough. This in turn prevents undesired moisture buildup within the cavity 224 of the domed portion 218 during use of the dressing 210 on the skin surface of the patient. The domed portion 218, together with the other portions of the dressing 210 cooperate to isolate the skin-placed medical device over which the dressing is disposed so as to prevent the incursion of microbes into the cavity 224 of the domed portion, thus preventing infection/compromise of the insertion site of the medical device through the skin of the patient.
An acrylic adhesive or other suitable adhesive is employed between the top surface of the dressing 252 and the bottom surface of the cover film 254 (from the perspective shown in
A support frame 256 is included to provide stiffness before and during placement of the dressing 210 over the skin-placed medical device and the skin of the patient. As seen in
A slit 310 is provided on the second support portion 308 to assist in removal of the afore-mentioned tape strip 264, as will be seen. Also, a hole 312 is included adjacent the date/time strip 262 to assist with removal of the date/time strip from the support frame 256, as will be seen. Similar holes can be positioned at other locations on the support frame to assist with the removal of other components removably attached to the support frame, in other embodiments. In yet another embodiment, slits in the support frame can be positioned proximate or under the date/time strip or other removable component so as to promote folding of the support frame and ease removal of the date/time strip from the support frame.
In the present embodiment, the support frame 256 includes a super-calendered kraft paper, though it is appreciated that other materials can also be employed, including polymers including polyethylene, polypropylene, polystyrene, etc. A silicone or other suitable coating is added to the top surface of the support frame 256 in the present embodiment to enable ease of removal of the tube securement assembly 260, date/time strip 262, and the tape strip 264 from the support frame. In the present embodiment, a suitable adhesive, such as a hot-melt adhesive, is applied to permit the attachment of the support frame to the cover film 254 and to permit separation thereof when desired. In one embodiment, the support frame material is pre-attached to the cover film material prior to assembly of the dressing 210. Other suitable support frame adhesives may also be employed.
A notch 322 is defined in the body of the tube securement assembly 260 and corresponds in position with a corresponding notch on the support frame 256 and the notch 271 on the release liner 250.
The tube securement assembly 260 is removably applied to the top surface of the support frame 256 on the first support portion 306 thereof, as shown in
Reference is now made to
Once the release liner 250 has been removed, the dressing 210 is placed over a medical device disposed on the skin of the patient, such as the infusion needle assembly 32 shown in
The tube securement assembly 260 is then removed from atop the support frame 256 and placed over the portion of the tubing 34 that extends from the notches 282, 292 so as to overlap both the skin of the patient and the adjacent portion of the dressing 210 and such that the notch 322 receives a portion of the tubing therein, as seen in
It is appreciated that in one embodiment the tube securement assembly is integrally formed with the dressing body; in another embodiment, no tube securement assembly is included. The size, shape, configuration, and placement of the tube securement assembly can also vary from what is shown and described herein. In another embodiment the securement assembly is used to secure components other than tubing. For instance, the securement assembly can be used to secure the dressing itself, in one embodiment.
Once the tube securement assembly 260 has been positioned, the support frame can then be removed from the dressing 210, as shown in
It is appreciated that, in one embodiment, no support frame is included in the dressing. In such a case, the release liner can optionally be made relatively thicker to provide for the desired stiffness of the dressing.
The dressing 210 is manufactured in one embodiment by first joining the dressing portion 252 to cover film 254. In particular, an adhesive (described further above) is applied to the top surface of the dressing portion 252 and the cover film 254, with the support frame 256 pre-attached thereto, is attached to the dressing portion. At this stage, the domed portion 218 has not yet been defined in the cover film 254.
The dressing portion 252 and joined cover film 254 can be pre-cut to define the respective sides 284, 294, or be cut after being joined together. The release liner 250 can then be joined to the bottom surface of the dressing portion 252. The holes 270, 280 of the respective release liner 250 and dressing portion 252 can be pre-defined or defined after joining of the release liner and the dressing portion. Excess material about the support frame 256 can be removed at this time, in the present embodiment.
The pre-assembled tube securement assembly 260 can be attached to the top surface of the support frame 256, as can the date/time strip 262 and the tape strip 264. Note that, in one embodiment, the final shapes of the tube securement assembly 260, the date/time strip 262, and the tape strip 264 can be defined at this stage via a die cut procedure. In another embodiment, the final shapes of these components can be pre-defined prior to attachment to the support frame 256.
Next, the assembled dressing 210 is electrostatically neutralized via an ionizer to eliminate static electricity before being introduced to a thermal forming process, wherein the dressing is positioned such that the holes 270 and 280 of the release liner 250 and the dressing portion 252 are aligned with a negative-type mold. A vacuum is applied and heat is introduced to the dressing so that the central portion of the cover film 254 is sucked on to and thermally formed about the mold, thus defining the pliable domed portion 218 in the cover film 254. In one embodiment, holes are included in the mold to assist in sucking the cover film on to the mold surface. Note that the release liner 250 acts as a heat shield to protect the dressing portion 252 and the cover film 254 from heat damage during the thermal forming process, in one embodiment. The heat and vacuum are then removed and the dressing 210 is allowed to cool, which causes the domed portion 218 to be permanently defined.
Note that the mold can be a negative or positive form of the desired shape for the domed portion 218. Indeed,
When forming the domed portion in the above-described manner utilizing a polyurethane cover film 254 of about 2 mils thickness as detailed further above, the thickness of the resultant domed portion 218 is from about 0.65 mil to about 1 mil, in one embodiment.
In other embodiments, other modes for forming the domed portion can be employed, including cold forming (rolling), injection molding, utilizing a pre-formed cover film, and dip casting, in which a form is repeatedly dipped into a molten polyurethane (or other suitable material) and solvent mixture to build up a domed portion cover film. These and other forming techniques are therefore contemplated. It is also appreciated that the above-described manufacturing steps are not exhaustive and that a different order of steps could be employed.
A releasable portion 416A included about a proximal perimeter of the central portion 416 is configured to be resealable so that access can be selectively made to the PICC 315 or other medical device enclosed within the domed portion 418. A pull-tab 419 or the like is included to facilitate lifting of the proximal portion of the central portion 416. When closed, the releasable portion 416A adheres to a releasable adhesive included on the perimeter portion 414 directly below the releasable portion, indicated in
Correspondingly, an adhered portion 416B is included about a distal perimeter of the central portion 416 and is configured to not separate from attachment with the perimeter portion 414. The adhesive used to secure the adhered portion 416B to the perimeter portion 414 can be the same adhesive as an adhesive 420 that is employed to secure the other portions of the central portion 416 to the perimeter portion 414. The relative sizes, shapes, and extents of both the releasable portion 416A and the adhered portion 416B can be varied from what is shown and described herein. A slit 422 can be included in the perimeter portion 414 to enable removal of the dressing 410 from over the medical device. As in other embodiments, the domed portion 418 can include a notch, or point 428, to fit over a portion of the covered medical device.
Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application claims the benefit of U.S. Provisional Patent Application No. 62/048,747, filed Sep. 10, 2014, and titled “Protective Dressing For Skin-Placed Medical Device,” which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
697637 | Lee | Apr 1902 | A |
RE24906 | Ulrich | Dec 1960 | E |
3389827 | Abere et al. | Jun 1968 | A |
3645835 | Hodgson | Feb 1972 | A |
3683911 | McCormick | Aug 1972 | A |
3782377 | Rychlik | Jan 1974 | A |
3824998 | Snyder | Jul 1974 | A |
3900026 | Wagner | Aug 1975 | A |
4112213 | Waldman | Sep 1978 | A |
4181127 | Linsky et al. | Jan 1980 | A |
4231369 | Sorensen et al. | Nov 1980 | A |
4275721 | Olson | Jun 1981 | A |
4310509 | Berglund et al. | Jan 1982 | A |
4323557 | Rosso et al. | Apr 1982 | A |
4366814 | Riedel | Jan 1983 | A |
4372303 | Grossmann et al. | Feb 1983 | A |
4373519 | Errede et al. | Feb 1983 | A |
4472480 | Olson | Sep 1984 | A |
4477325 | Osburn | Oct 1984 | A |
4499896 | Heinecke | Feb 1985 | A |
4519793 | Galindo | May 1985 | A |
4524087 | Engel | Jun 1985 | A |
4534762 | Heyer | Aug 1985 | A |
4551490 | Doyle et al. | Nov 1985 | A |
4565663 | Errede et al. | Jan 1986 | A |
4598004 | Heinecke | Jul 1986 | A |
4600001 | Gilman | Jul 1986 | A |
4614183 | McCracken et al. | Sep 1986 | A |
4619253 | Anhauser et al. | Oct 1986 | A |
4633863 | Filips et al. | Jan 1987 | A |
4667666 | Fryslie | May 1987 | A |
4669458 | Abraham et al. | Jun 1987 | A |
4675006 | Hrushesky | Jun 1987 | A |
4678462 | Vaillancourt | Jul 1987 | A |
4693776 | Krampe et al. | Sep 1987 | A |
4706662 | Thompson | Nov 1987 | A |
4728323 | Matson | Mar 1988 | A |
4737410 | Kantner | Apr 1988 | A |
4738257 | Meyer et al. | Apr 1988 | A |
4769028 | Hoffmann et al. | Sep 1988 | A |
4773408 | Cilento et al. | Sep 1988 | A |
4830914 | Vaillancourt | May 1989 | A |
4867150 | Gilbert | Sep 1989 | A |
4867742 | Calderon | Sep 1989 | A |
4867748 | Samuelsen | Sep 1989 | A |
4898587 | Mera | Feb 1990 | A |
4901714 | Jensen | Feb 1990 | A |
4909244 | Quarfoot et al. | Mar 1990 | A |
4917112 | Kalt | Apr 1990 | A |
4917928 | Heinecke | Apr 1990 | A |
4917929 | Heinecke | Apr 1990 | A |
4919654 | Kalt | Apr 1990 | A |
4931282 | Asmus et al. | Jun 1990 | A |
4944040 | Riedel et al. | Jul 1990 | A |
4948575 | Cole et al. | Aug 1990 | A |
4952618 | Olsen | Aug 1990 | A |
RE33353 | Heinecke | Sep 1990 | E |
4956350 | Mosbey | Sep 1990 | A |
4977892 | Ewall | Dec 1990 | A |
4988341 | Columbus et al. | Jan 1991 | A |
5000172 | Ward | Mar 1991 | A |
5009224 | Cole | Apr 1991 | A |
5017625 | Ansell | May 1991 | A |
5059424 | Cartmell et al. | Oct 1991 | A |
5074847 | Greenwell et al. | Dec 1991 | A |
5088483 | Heinecke | Feb 1992 | A |
5106629 | Cartmell et al. | Apr 1992 | A |
5113860 | McQuinn | May 1992 | A |
5133821 | Jensen | Jul 1992 | A |
5151314 | Brown | Sep 1992 | A |
5153040 | Faasse, Jr. | Oct 1992 | A |
5156601 | Lorenz et al. | Oct 1992 | A |
5160315 | Heinecke et al. | Nov 1992 | A |
5197945 | Cole et al. | Mar 1993 | A |
5225473 | Duan | Jul 1993 | A |
5236421 | Becher | Aug 1993 | A |
5244677 | Kreckel et al. | Sep 1993 | A |
5250043 | Castellana et al. | Oct 1993 | A |
5266371 | Sugii et al. | Nov 1993 | A |
5270358 | Asmus | Dec 1993 | A |
5276079 | Duan et al. | Jan 1994 | A |
5282791 | Lipton et al. | Feb 1994 | A |
5308887 | Ko et al. | May 1994 | A |
5338490 | Dietz et al. | Aug 1994 | A |
5340363 | Fabo | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5356632 | Gross et al. | Oct 1994 | A |
5384174 | Ward et al. | Jan 1995 | A |
5386835 | Elphick et al. | Feb 1995 | A |
5389376 | Duan et al. | Feb 1995 | A |
5409472 | Rawlings et al. | Apr 1995 | A |
5409966 | Duan et al. | Apr 1995 | A |
5413567 | Barth et al. | May 1995 | A |
5415642 | Shepherd | May 1995 | A |
5423737 | Cartmell et al. | Jun 1995 | A |
5437622 | Carion | Aug 1995 | A |
5438988 | Duan et al. | Aug 1995 | A |
5447492 | Cartmell et al. | Sep 1995 | A |
5509915 | Hanson et al. | Apr 1996 | A |
5512041 | Bogart | Apr 1996 | A |
5520629 | Heinecke et al. | May 1996 | A |
5531855 | Heinecke et al. | Jul 1996 | A |
5536544 | Liegeois | Jul 1996 | A |
5540922 | Fabo | Jul 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5593395 | Martz | Jan 1997 | A |
5603946 | Constantine | Feb 1997 | A |
5605546 | Wolzinger et al. | Feb 1997 | A |
5616387 | Augst et al. | Apr 1997 | A |
5618556 | Johns et al. | Apr 1997 | A |
5622711 | Chen | Apr 1997 | A |
5633010 | Chen | May 1997 | A |
5637080 | Geng | Jun 1997 | A |
5639469 | Benes et al. | Jun 1997 | A |
5643187 | N.ae butted.stoft et al. | Jul 1997 | A |
5653699 | Reed et al. | Aug 1997 | A |
5670557 | Dietz et al. | Sep 1997 | A |
5674523 | Cartmell et al. | Oct 1997 | A |
5674561 | Dietz et al. | Oct 1997 | A |
5704905 | Jensen et al. | Jan 1998 | A |
5709651 | Ward | Jan 1998 | A |
5713842 | Kay | Feb 1998 | A |
5714225 | Hansen et al. | Feb 1998 | A |
5728071 | Watson et al. | Mar 1998 | A |
5733251 | Johns | Mar 1998 | A |
5733570 | Chen et al. | Mar 1998 | A |
5738642 | Heinecke et al. | Apr 1998 | A |
5750134 | Scholz et al. | May 1998 | A |
5750136 | Scholz et al. | May 1998 | A |
5755681 | Plews | May 1998 | A |
5780045 | McQuinn et al. | Jul 1998 | A |
5782787 | Webster | Jul 1998 | A |
5792089 | Penrose et al. | Aug 1998 | A |
5840052 | Johns | Nov 1998 | A |
5846214 | Makuuchi et al. | Dec 1998 | A |
5846558 | Nielsen et al. | Dec 1998 | A |
5849325 | Heinecke et al. | Dec 1998 | A |
5853750 | Dietz et al. | Dec 1998 | A |
5885254 | Matyas | Mar 1999 | A |
5887590 | Price | Mar 1999 | A |
D408541 | Dunshee et al. | Apr 1999 | S |
5891076 | Fabo | Apr 1999 | A |
D409754 | Dunshee et al. | May 1999 | S |
D410087 | Dunshee et al. | May 1999 | S |
5939339 | Delmore et al. | Aug 1999 | A |
5941840 | Court et al. | Aug 1999 | A |
5947917 | Carte et al. | Sep 1999 | A |
5951505 | Gilman et al. | Sep 1999 | A |
5952398 | Dietz et al. | Sep 1999 | A |
5968533 | Porter et al. | Oct 1999 | A |
5973221 | Collyer et al. | Oct 1999 | A |
5976117 | Dunshee et al. | Nov 1999 | A |
5985990 | Kantner et al. | Nov 1999 | A |
6008429 | Ritger | Dec 1999 | A |
6043408 | Geng | Mar 2000 | A |
6090076 | Lane, Jr. | Jul 2000 | A |
6103369 | Lucast et al. | Aug 2000 | A |
D430674 | Dunshee et al. | Sep 2000 | S |
6121508 | Bischof et al. | Sep 2000 | A |
6124520 | Roberts | Sep 2000 | A |
6124521 | Roberts | Sep 2000 | A |
6129971 | Brandt et al. | Oct 2000 | A |
6139868 | Hoffmann | Oct 2000 | A |
6140548 | Hansen et al. | Oct 2000 | A |
6149614 | Dunshee et al. | Nov 2000 | A |
6168800 | Dobos et al. | Jan 2001 | B1 |
6169224 | Heinecke et al. | Jan 2001 | B1 |
6191339 | Gueret | Feb 2001 | B1 |
6197397 | Sher et al. | Mar 2001 | B1 |
6198016 | Lucast et al. | Mar 2001 | B1 |
6210704 | Sasaki et al. | Apr 2001 | B1 |
6225521 | Gueret | May 2001 | B1 |
6255552 | Cummings et al. | Jul 2001 | B1 |
6264976 | Heinecke et al. | Jul 2001 | B1 |
6302867 | Brown, Jr. et al. | Oct 2001 | B1 |
6309500 | Jensen et al. | Oct 2001 | B1 |
D454955 | Dunshee et al. | Mar 2002 | S |
6387495 | Reeves et al. | May 2002 | B1 |
6420622 | Johnston et al. | Jul 2002 | B1 |
6429154 | Trotter | Aug 2002 | B1 |
6436432 | Heinecke et al. | Aug 2002 | B2 |
6461467 | Blatchford et al. | Oct 2002 | B2 |
6468383 | Kundel | Oct 2002 | B2 |
6479073 | Lucast et al. | Nov 2002 | B1 |
6518343 | Lucast et al. | Feb 2003 | B1 |
D473947 | Jacobson | Apr 2003 | S |
6552244 | Jacques et al. | Apr 2003 | B1 |
D474842 | Wolsing et al. | May 2003 | S |
6566575 | Stickels et al. | May 2003 | B1 |
6566577 | Addison et al. | May 2003 | B1 |
6607799 | Heinecke et al. | Aug 2003 | B1 |
D480144 | Adams et al. | Sep 2003 | S |
D484601 | Griffiths et al. | Dec 2003 | S |
D484602 | Griffiths et al. | Dec 2003 | S |
6663584 | Griesbach, III et al. | Dec 2003 | B2 |
6680113 | Lucast et al. | Jan 2004 | B1 |
6685682 | Heinecke | Feb 2004 | B1 |
6727402 | Bruss et al. | Apr 2004 | B1 |
D492411 | Bierman | Jun 2004 | S |
6756102 | Galo | Jun 2004 | B1 |
6809230 | Hancock et al. | Oct 2004 | B2 |
6822132 | Ahrens et al. | Nov 2004 | B2 |
6827707 | Wright et al. | Dec 2004 | B2 |
6838589 | Liedtke et al. | Jan 2005 | B2 |
6841715 | Roberts | Jan 2005 | B2 |
D501559 | Shaw et al. | Feb 2005 | S |
6867342 | Johnston et al. | Mar 2005 | B2 |
D503982 | Liedtke et al. | Apr 2005 | S |
6878385 | Jensen et al. | Apr 2005 | B2 |
6888042 | Freeman | May 2005 | B1 |
6897348 | Malik | May 2005 | B2 |
6903151 | Lucast et al. | Jun 2005 | B2 |
6903243 | Burton | Jun 2005 | B1 |
6911243 | Sher et al. | Jun 2005 | B2 |
6927315 | Heinecke et al. | Aug 2005 | B1 |
D511005 | Liedtke et al. | Oct 2005 | S |
6955659 | Carter | Oct 2005 | B1 |
D512509 | Yamasoto et al. | Dec 2005 | S |
6987209 | Augustine et al. | Jan 2006 | B2 |
6994904 | Joseph et al. | Feb 2006 | B2 |
6998511 | Worthley | Feb 2006 | B2 |
7005031 | Lucast et al. | Feb 2006 | B2 |
D516729 | Liedtke et al. | Mar 2006 | S |
7030288 | Liedtke et al. | Apr 2006 | B2 |
7049479 | Cleary et al. | May 2006 | B2 |
D524946 | Shaw et al. | Jul 2006 | S |
7094944 | Faasse, Jr. | Aug 2006 | B2 |
7129389 | Watson | Oct 2006 | B1 |
7135606 | Dozier et al. | Nov 2006 | B1 |
7182085 | Larsen et al. | Feb 2007 | B1 |
7182955 | Hart et al. | Feb 2007 | B2 |
7183454 | Rosenberg | Feb 2007 | B1 |
D537948 | Smith | Mar 2007 | S |
7217853 | Kulichikhin et al. | May 2007 | B2 |
7223899 | Sigurjonsson | May 2007 | B2 |
D545440 | Jensen | Jun 2007 | S |
7232454 | Rousseau | Jun 2007 | B2 |
7279177 | Looney et al. | Oct 2007 | B2 |
7294751 | Propp et al. | Nov 2007 | B2 |
7294752 | Propp | Nov 2007 | B1 |
D557424 | Knight | Dec 2007 | S |
7304202 | Sigurjonsson et al. | Dec 2007 | B2 |
7316840 | Neculescu et al. | Jan 2008 | B2 |
7317134 | Faasse, Jr. | Jan 2008 | B2 |
7344512 | Yamazaki et al. | Mar 2008 | B2 |
D572824 | Propp | Jul 2008 | S |
D573260 | Dunshee | Jul 2008 | S |
7396975 | Sigurjonsson et al. | Jul 2008 | B2 |
7442849 | Heinecke | Oct 2008 | B2 |
7531711 | Sigurjonsson et al. | May 2009 | B2 |
7563941 | Lebner et al. | Jul 2009 | B2 |
7576256 | Bjomberg et al. | Aug 2009 | B2 |
7585554 | Johnson et al. | Sep 2009 | B2 |
D601707 | Chouiller | Oct 2009 | S |
7598298 | Lewandowski et al. | Oct 2009 | B2 |
7615674 | Asherman | Nov 2009 | B2 |
7624869 | Primer | Dec 2009 | B2 |
7626070 | Propp | Dec 2009 | B2 |
7674948 | Propp et al. | Mar 2010 | B2 |
7691096 | Gillis | Apr 2010 | B2 |
7723561 | Propp | May 2010 | B2 |
D620123 | Igwebuike | Jul 2010 | S |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7781639 | Johnston et al. | Aug 2010 | B2 |
7807661 | Ylitalo et al. | Oct 2010 | B2 |
7812212 | Propp et al. | Oct 2010 | B2 |
7858838 | Holm et al. | Dec 2010 | B2 |
7888546 | Marcoux et al. | Feb 2011 | B2 |
D634423 | Heinecke et al. | Mar 2011 | S |
7910790 | Johnston et al. | Mar 2011 | B2 |
7981087 | Gesler, III | Jul 2011 | B2 |
7988673 | Wright et al. | Aug 2011 | B2 |
7994381 | Baron et al. | Aug 2011 | B2 |
8002113 | Cummings | Aug 2011 | B1 |
8049057 | Propp | Nov 2011 | B2 |
8049058 | Propp | Nov 2011 | B2 |
8053623 | Propp | Nov 2011 | B2 |
8053624 | Propp | Nov 2011 | B2 |
8084665 | Liedtke et al. | Dec 2011 | B2 |
8093445 | Sigurjonsson et al. | Jan 2012 | B2 |
8110718 | Heinecke | Feb 2012 | B2 |
8158845 | Qin et al. | Apr 2012 | B2 |
8173113 | Scholz et al. | May 2012 | B1 |
8197447 | Wright | Jun 2012 | B2 |
8212101 | Propp | Jul 2012 | B2 |
8237009 | Siniaguine | Aug 2012 | B2 |
8247635 | Sigurjonsson et al. | Aug 2012 | B2 |
8269059 | Wright et al. | Sep 2012 | B2 |
D672464 | Holm et al. | Dec 2012 | S |
8344201 | Madsen et al. | Jan 2013 | B2 |
8372051 | Scholz et al. | Feb 2013 | B2 |
8404921 | Lee et al. | Mar 2013 | B2 |
D679392 | Peterson et al. | Apr 2013 | S |
D679402 | Conrad-Vlasak et al. | Apr 2013 | S |
D679403 | Heinecke et al. | Apr 2013 | S |
8409157 | Haggstrom et al. | Apr 2013 | B2 |
8410332 | Burton et al. | Apr 2013 | B2 |
8450553 | Utterberg et al. | May 2013 | B2 |
D683858 | Smith | Jun 2013 | S |
8486004 | Propp | Jul 2013 | B1 |
D687555 | Peterson et al. | Aug 2013 | S |
D688377 | Heinecke et al. | Aug 2013 | S |
8513481 | Gergely et al. | Aug 2013 | B2 |
D690425 | Heinecke et al. | Sep 2013 | S |
8530022 | Fabo et al. | Sep 2013 | B2 |
D693010 | Mosa et al. | Nov 2013 | S |
D695901 | Heinecke et al. | Dec 2013 | S |
8604265 | Locke et al. | Dec 2013 | B2 |
8663171 | Tambourgi et al. | Mar 2014 | B2 |
8672905 | Riesinger | Mar 2014 | B2 |
D704343 | Inoo et al. | May 2014 | S |
D710017 | Mosa et al. | Jul 2014 | S |
8764714 | Fabo et al. | Jul 2014 | B2 |
D712046 | Igwebuike et al. | Aug 2014 | S |
D712549 | Igwebuike et al. | Sep 2014 | S |
D712550 | Igwebuike et al. | Sep 2014 | S |
8906815 | Moore et al. | Dec 2014 | B2 |
9000252 | Bradford et al. | Apr 2015 | B2 |
D729391 | Igwebuike et al. | May 2015 | S |
9029625 | Effing et al. | May 2015 | B2 |
9168180 | Ha | Oct 2015 | B2 |
20010027285 | Heinecke et al. | Oct 2001 | A1 |
20010031370 | Kundel | Oct 2001 | A1 |
20010051178 | Blatchford et al. | Dec 2001 | A1 |
20020082540 | Johnston et al. | Jun 2002 | A1 |
20020128578 | Johnston et al. | Sep 2002 | A1 |
20030007999 | Blatchford et al. | Jan 2003 | A1 |
20030125680 | Ding | Jul 2003 | A1 |
20040133143 | Burton et al. | Jul 2004 | A1 |
20040143220 | Worthley | Jul 2004 | A1 |
20040158209 | Wright | Aug 2004 | A1 |
20040247654 | Asmus et al. | Dec 2004 | A1 |
20040247655 | Asmus et al. | Dec 2004 | A1 |
20050080372 | Nielsen et al. | Apr 2005 | A1 |
20050228352 | Heinecke et al. | Oct 2005 | A1 |
20060003133 | Johnson | Jan 2006 | A1 |
20060064049 | Marcussen | Mar 2006 | A1 |
20070027423 | Scheinberg | Feb 2007 | A1 |
20070060892 | Propp | Mar 2007 | A1 |
20070073211 | Propp | Mar 2007 | A1 |
20070078400 | Gesler | Apr 2007 | A1 |
20070106265 | Gillis | May 2007 | A1 |
20070156075 | Heinecke | Jul 2007 | A1 |
20070179419 | Simpson | Aug 2007 | A1 |
20080058692 | Propp et al. | Mar 2008 | A1 |
20080063695 | Vitaris | Mar 2008 | A1 |
20080132821 | Propp et al. | Jun 2008 | A1 |
20080281245 | Effing et al. | Nov 2008 | A1 |
20080312574 | Pernot | Dec 2008 | A1 |
20090082710 | Vitaris | Mar 2009 | A1 |
20090187130 | Asmus et al. | Jul 2009 | A1 |
20090192470 | Propp | Jul 2009 | A1 |
20090247965 | Williams | Oct 2009 | A1 |
20100004680 | Propp | Jan 2010 | A1 |
20100106113 | Heinecke | Apr 2010 | A1 |
20100106114 | Weston | Apr 2010 | A1 |
20100121282 | Propp | May 2010 | A1 |
20100159192 | Cotton | Jun 2010 | A1 |
20100160866 | Propp | Jun 2010 | A1 |
20100198161 | Propp | Aug 2010 | A1 |
20100198162 | Propp | Aug 2010 | A1 |
20100318013 | Fabo et al. | Dec 2010 | A1 |
20100318052 | Ha et al. | Dec 2010 | A1 |
20100318072 | Johnston et al. | Dec 2010 | A1 |
20110004139 | Pigg | Jan 2011 | A1 |
20110015556 | Fabo et al. | Jan 2011 | A1 |
20110052665 | Hardy et al. | Mar 2011 | A1 |
20110098622 | Hatanaka et al. | Apr 2011 | A1 |
20110130738 | Schmidt | Jun 2011 | A1 |
20110166492 | Holm et al. | Jul 2011 | A1 |
20110257574 | Svensby | Oct 2011 | A1 |
20110280926 | Junginger | Nov 2011 | A1 |
20110282292 | Polowy et al. | Nov 2011 | A1 |
20120010572 | Bennett | Jan 2012 | A1 |
20120083723 | Vitaris et al. | Apr 2012 | A1 |
20120109069 | Dickert et al. | May 2012 | A1 |
20120109070 | Elsamahy et al. | May 2012 | A1 |
20120150122 | Harper | Jun 2012 | A1 |
20120197206 | Glenn | Aug 2012 | A1 |
20120238932 | Atteia et al. | Sep 2012 | A1 |
20130018322 | Wright | Jan 2013 | A1 |
20130053747 | Lin | Feb 2013 | A1 |
20130102945 | Long | Apr 2013 | A1 |
20130138063 | Wiltshire et al. | May 2013 | A1 |
20130150796 | Souza et al. | Jun 2013 | A1 |
20130152944 | Okada et al. | Jun 2013 | A1 |
20130165865 | Kelvered et al. | Jun 2013 | A1 |
20130172843 | Kurata | Jul 2013 | A1 |
20130211347 | Arbel et al. | Aug 2013 | A1 |
20130218085 | Knobloch | Aug 2013 | A1 |
20130220347 | Al Otaibi | Aug 2013 | A1 |
20130281906 | Fabo et al. | Oct 2013 | A1 |
20130310754 | Kutsch | Nov 2013 | A1 |
20130317405 | Ha et al. | Nov 2013 | A1 |
20130317406 | Locke et al. | Nov 2013 | A1 |
20140005607 | Elsamahy et al. | Jan 2014 | A1 |
20140058309 | Addison et al. | Feb 2014 | A1 |
20140066867 | Locke et al. | Mar 2014 | A1 |
20140107561 | Dorian et al. | Apr 2014 | A1 |
20140121638 | Mosa et al. | May 2014 | A1 |
20140121649 | Calco | May 2014 | A1 |
20140142490 | Johannison | May 2014 | A1 |
20140142526 | Auguste et al. | May 2014 | A1 |
20140158572 | Jensen | Jun 2014 | A1 |
20140243728 | Igwebuike et al. | Aug 2014 | A1 |
20140249495 | Mumby et al. | Sep 2014 | A1 |
20140257242 | Sung | Sep 2014 | A1 |
20140316353 | Riesinger | Oct 2014 | A1 |
20150005688 | Goby | Jan 2015 | A1 |
20150088085 | Rovaniemi | Mar 2015 | A1 |
20150141949 | Decabooter et al. | May 2015 | A1 |
20150157509 | Atkinson et al. | Jun 2015 | A1 |
20150209188 | Scheremet et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
5193 | Nov 1979 | EP |
368541 | May 1990 | EP |
424165 | Apr 1991 | EP |
919211 | Jun 1999 | EP |
1457164 | Dec 1976 | GB |
1984003837 | Oct 1984 | WO |
1992016245 | Oct 1992 | WO |
1994012134 | Jun 1994 | WO |
1994021207 | Sep 1994 | WO |
1998000080 | Jan 1998 | WO |
1998015245 | Apr 1998 | WO |
1999006077 | Feb 1999 | WO |
1999027975 | Jun 1999 | WO |
0149233 | Jul 2001 | WO |
0220067 | Mar 2002 | WO |
0234304 | May 2002 | WO |
0380133 | Oct 2003 | WO |
2004026389 | Apr 2004 | WO |
2007034393 | Mar 2007 | WO |
2009075636 | Jun 2009 | WO |
2012083965 | Jun 2012 | WO |
2012125530 | Sep 2012 | WO |
2013057508 | Apr 2013 | WO |
2013082883 | Jun 2013 | WO |
2013096027 | Jun 2013 | WO |
2013162680 | Oct 2013 | WO |
2013173588 | Nov 2013 | WO |
2014020440 | Feb 2014 | WO |
2014020443 | Feb 2014 | WO |
2014051040 | Apr 2014 | WO |
2014081626 | May 2014 | WO |
2014097069 | Jun 2014 | WO |
2014099709 | Jun 2014 | WO |
2014120746 | Aug 2014 | WO |
2015022334 | Feb 2015 | WO |
2015022340 | Feb 2015 | WO |
2015050749 | Apr 2015 | WO |
2015102981 | Jul 2015 | WO |
2015130608 | Sep 2015 | WO |
2016040695 | Mar 2016 | WO |
Entry |
---|
US 7,390,501 B2, 06/2008, Hart et al. (withdrawn) |
3M “3M Tegaderm and Tegaderm HP Transparent Dressings” 2005. |
3M “3M Tegaderm IV Advanced Securement Dressings”, (1 of 2) 2011. |
3M “3M Tegaderm IV Advanced Securement Dressings”, (2 of 2) 2011. |
3M “Tegaderm Full Line of IV Site Dressings” brochure. 2012. |
3M Tegaderm Transparent Dressing—2-3/8x2-3/4in., 2013. |
3M Tegaderm Transparent Dressing—4x4,3/4in., 2013. |
3M Tegaderm Transparent Dressing—6x8in., 2013. |
3M Tegaderm Transparent Dressing—Film Roll, 2005. |
3M Tegaderm Transparent Dressing—Notched 4x4,3/4in., 2013. |
3M Tegaderm Transparent Dressing FAQ Jan. 26, 2007. |
3M Tegaderm Transparent Dressing I.F.U. 1999. |
Centurion “Dressings and securement products” brochure. 2011. |
Medline “Today's wound care treatments”, Jun. 2012. |
Molnlychke Health Care “Mepore Film, formerly Mefilm”, 2007. |
PCT/US2015/049517 filed Sep. 10, 2015 International Search Report and Written Opinion dated Jan. 21, 2016. |
EP 15839400.7 filed Mar. 16, 2017 Extended European Search Report dated Mar. 16, 2018. |
EP 15839400.7 filed Mar. 16, 2017 Partial European Search Report dated Mar. 16, 2018. |
Number | Date | Country | |
---|---|---|---|
20160067106 A1 | Mar 2016 | US |
Number | Date | Country | |
---|---|---|---|
62048747 | Sep 2014 | US |